

Methylnaltrexone potentiates body weight and fat reduction with leptin
Abstract
Results: Compared with control, the weight gain of pups given a single daily intraperitoneal injection of leptin 0.5 mg/kg, leptin 0.5 mg/kg plus naloxone 0.3 mg/kg, or leptin 0.5 mg/kg plus methylnaltrexone 3.0 mg/kg for 8 consecutive days was significantly reduced (all p < 0.01). Naloxone or methylnaltrexone significantly potentiated leptin’s effect on body weight (p < 0.05 or p < 0.01, respectively). After coadministration of leptin plus naloxone or leptin plus methylnaltrexone, weight reduction in the right retroperitoneal fat pads was also significant compared with the reduction after leptin alone (p < 0.05 or p < 0.01, respectively).
Conclusions: The data suggest the existence of a peripheral opioid-related mechanism in leptinactive modulation of body weight.
Keywords
References
Jequier E: Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci. 2002; 967: 379-388.
Arora S, Anubhuti: Role of neuropeptides in appetite regulation and obesity–A review. Neuropeptides. 2006; 40: 375-401.
Zhang Y, Proenca R, Maffei M, et al.: Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372: 425-432.
Campfield LA, Smith FJ, Guisez Y, et al.: Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995; 269: 546-549.
Attele AS, Shi ZQ, Yuan CS: Leptin, gut, and food intake. Biochem Pharmacol. 2002; 63: 1579-1583.
Wiwanitkit V: Interaction between leptin and leptin receptor in gastric carcinoma: gene ontology analysis. Rev Esp Enferm Dig. 2007; 99: 201-205.
Yuan CS, Attele AS, Dey L, et al.: Gastric effects of cholecystokinin and its interaction with leptin on brainstem neuronal activity in neonatal rats. J Pharmacol Exp Ther. 2000; 295: 177-182.
Yuan CS, Dey L, Xie JT, et al.: Gastric effects of galanin and its interaction with leptin on brainstem neuronal activity. J Pharmacol Exp Ther. 2002; 301: 488-493.
Shi ZQ, Nelson A, Whitcomb L, et al.: Intracerebroventricular administration of leptin markedly enhances insulin sensitivity and systemic glucose utilization in conscious rats. Metabolism. 1998; 47: 1274-1280.
Wang JL, Chinookoswong N, Scully S, et al.: Differential effects of leptin in regulation of tissue glucose utilization in vivo. Endocrinology. 1999; 140: 2117-2124.
Halaas JL, Gajiwala KS, Maffei M, et al.: Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995; 269: 543-546.
Yuan CS, Attele AS, Zhang L, et al.: Leptin reduces body weight gain in neonatal rats. Pediatr Res. 2000; 48: 380-383.
Ahima RS, Antwi DA: Brain regulation of appetite and satiety. Endocrinol Metab Clin North Am. 2008; 37: 811-823.
Kotz CM, Grace MK, Briggs J, et al.: Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action. J Clin Invest. 1995; 96: 163-170.
Appleyard SM, Hayward M, Young JI, et al.: A role for the endogenous opioid beta-endorphin in energy homeostasis. Endocrinology. 2003; 144: 1753-1760.
Cao WH, Morrison SF: Brown adipose tissue thermogenesis contributes to fentanyl-evoked hyperthermia. Am J Physiol Regul Integr Comp Physiol. 2005; 288: R723-R732.
Yuan CS: Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects. Ann Pharmacother. 2007; 41: 984-993.
Ravishankar Ram M, Beena G, Ragunathan P, et al.: Analysis of structure, function, and evolutionary origin of the ob gene product—leptin. J Biomol Struct Dyn. 2007; 25: 183-188.
Bado A, Levasseur S, Attoub S, et al.: The stomach is a source of leptin. Nature. 1998; 394: 790-793.
Mix H, Manns MP, Wagner S, et al.: Expression of leptin and its receptor in the human stomach. Gastroenterology. 1999; 117: 509.
Hukshorn CJ, Saris WH: Leptin and energy expenditure. Curr Opin Clin Nutr Metab Care. 2004; 7: 629-633.
Dhillo WS: Appetite regulation: An overview. Thyroid. 2007; 17: 433-445.
Cramer CP, Blass EM: Mechanisms of control of milk intake in suckling rats. Am J Physiol. 1983; 245: R154-R159.
Bernardis LL, Bellinger LL: The dorsomedial hypothalamic nucleus revisited: 1998 update. Proc Soc Exp Biol Med. 1998; 218: 284-306.
Himms-Hagen J, Ricquier D: Brown adipose tissue. In Bray GA, James WPT (ed.): Hand-book of Obesity, New York: Marcel Decker, 1997: 415-432.
Cozzolino D, Sessa G, Salvatore T, et al.: The involvement of the opioid system in human obesity: A study in normal weight relatives of obese people. J Clin Endocrinol Metab. 1996; 81: 713-718.
Shalev U, Yap J, Shaham Y: Leptin attenuates acute food deprivation-induced relapse to heroin seeking. J Neurosci. 2001; 21: RC129.
Baile CA, McLaughlin CL, Della-Fera MA: Role of cholecystokinin and opioid peptides in control of food intake. Physiol Rev. 1986; 66: 172-234.
Yuan CS, Israel RJ: Methylnaltrexone: A peripherally acting opioid antagonist. In Dean R, Bilsky EJ, Negus SS (eds.): Opiate Receptors and Antagonists. New York, NY: Humana Press, 2009: 175-198.
DOI: https://doi.org/10.5055/jom.2009.0037
Refbacks
- There are currently no refbacks.